Gianviti Alessandra, Tozzi Alberto E, De Petris Laura, Caprioli Alfredo, Ravà Lucilla, Edefonti Alberto, Ardissino Gianluigi, Montini Giovanni, Zacchello Graziella, Ferretti Alfonso, Pecoraro Carmine, De Palo Tommaso, Caringella Angela, Gaido Maurizio, Coppo Rosanna, Perfumo Francesco, Miglietti Nunzia, Ratsche Ilse, Penza Rosa, Capasso Giovambattista, Maringhini Silvio, Li Volti Salvatore, Setzu Carmen, Pennesi Marco, Bettinelli Alberto, Peratoner Leopoldo, Pela Ivana, Salvaggio Elio, Lama Giuliana, Maffei Salvatore, Rizzoni Gianfranco
Division of Nephrology and Dialysis, Bambino Gesù Children's Hospital and Institute for Scientific Research, Rome, Italy.
Pediatr Nephrol. 2003 Dec;18(12):1229-35. doi: 10.1007/s00467-003-1262-6. Epub 2003 Oct 31.
Many factors have been proposed as predictors of poor renal prognosis in children with hemolytic uremic syndrome (HUS), but their role is still controversial. Our aim was to detect the most reliable early predictors of poor renal prognosis to promptly identify children at major risk of bad outcome who could eventually benefit from early specific treatments, such as plasmapheresis. Prognostic factors identifiable at onset of HUS were evaluated by survival analysis and a proportional hazard model. These included age at onset, prodromal diarrhea (D), leukocyte count, central nervous system (CNS) involvement, and evidence of Shiga toxin-producing Escherichia coli (STEC) infection. Three hundred and eighty-seven HUS cases were reported; 276 were investigated for STEC infection and 189 (68%) proved positive. Age at onset, leukocyte count, and CNS involvement were not associated with the time to recovery. Absence of prodromal D and lack of evidence of STEC infection were independently associated with a poor renal prognosis; only 34% of patients D(-)STEC(- )recovered normal renal function compared with 65%-76% of D(+)STEC(+), D(+)STEC(-) and D(-)STEC(+ )patients. In conclusion, absence of both D and evidence of STEC infection are needed to identify patients with HUS and worst prognosis, while D(-) but STEC(+) patients have a significantly better prognosis.
许多因素已被提出作为溶血尿毒综合征(HUS)患儿肾脏预后不良的预测指标,但其作用仍存在争议。我们的目的是检测最可靠的肾脏预后不良早期预测指标,以便及时识别出最终可能从早期特异性治疗(如血浆置换)中获益的、具有不良结局重大风险的患儿。通过生存分析和比例风险模型评估HUS发病时可识别的预后因素。这些因素包括发病年龄、前驱性腹泻(D)、白细胞计数、中枢神经系统(CNS)受累情况以及产志贺毒素大肠杆菌(STEC)感染的证据。报告了387例HUS病例;对其中276例进行了STEC感染调查,189例(68%)结果呈阳性。发病年龄、白细胞计数和CNS受累情况与恢复时间无关。无前驱性腹泻且缺乏STEC感染证据与肾脏预后不良独立相关;D(-)STEC(-)患者中只有34%恢复了正常肾功能,而D(+)STEC(+)、D(+)STEC(-)和D(-)STEC(+)患者的这一比例为65%-76%。总之,需要同时具备无前驱性腹泻和STEC感染证据才能识别出HUS且预后最差的患者,而D(-)但STEC(+)的患者预后明显较好。